方达控股(01521)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01521 方达控股

已收盘 12-19 16:08:47

1.650

+0.040

+2.48%

最高1.650	最低1.610	成交量172.40万
今开1.610	昨收1.610	日振幅2.48%
总市值33.59亿	流通市值33.59亿	总股本20.36亿
成交额281.32万	换手率0.08%	流通股本20.36亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01521","market":"HK","secType":"STK","nameCN":"方达控股","latestPrice":1.65,"timestamp":1734595727013,"preClose":1.61,"halted":0,"volume":1724000,"delay":0,"floatShares":2035724910,"shares":2035724910,"eps":0.04119687,"marketStatus":"已收盘","marketStatusCode":5,"change":0.04,"latestTime":"12-19 16:08:47","open":1.61,"high":1.65,"low":1.61,"amount":2813216,"amplitude":0.024845,"askPrice":1.65,"askSize":88000,"bidPrice":1.62,"bidSize":36000,"shortable":0,"etf":0,"ttmEps":0.022783471485668963,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734658200000},"adr":0,"listingDate":1559145600000,"adjPreClose":1.61,"openAndCloseTimeList":[[1734571800000,1734580800000],[1734584400000,1734595200000]],"volumeRatio":1.740711,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01521","defaultTab":"news","newsList":[{"id":"2491340986","title":"方达控股(01521)上涨5.3%，报1.59元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2491340986","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491340986?lang=zh_cn&edition=full","pubTime":"2024-12-16 14:16","pubTimestamp":1734329760,"startTime":"0","endTime":"0","summary":"12月16日，方达控股(01521)盘中上涨5.3%，截至14:16，报1.59元/股，成交108.48万元。方达控股公司是一家提供全方位一体化的医药研发合同研究服务，主要为仿制药和创新药公司提供从新药可行性研究到临床研究的全过程产品开发服务。公司已成功帮助客户将数以百计的化合物从产品研发阶段推进到商业化，遵循严谨的科学技术和质量体系，确保每个项目的高品质及合规性。截至2024年中报，方达控股营业总收入9.16亿元、净利润-83.38万元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/16141646413258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01521","BK1576","BK1583","BK1141"],"gpt_icon":0},{"id":"2491328632","title":"方达控股盘中异动 下午盘快速上涨5.30%报1.590港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491328632","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491328632?lang=zh_cn&edition=full","pubTime":"2024-12-16 14:15","pubTimestamp":1734329754,"startTime":"0","endTime":"0","summary":"2024年12月16日下午盘14时15分，方达控股股票出现异动，股价快速上涨5.30%。截至发稿，该股报1.590港元/股，成交量69万股，换手率0.03%，振幅3.97%。资金方面，该股资金流入66.9万港元，流出41.27万港元。方达控股股票所在的生物技术行业中，整体跌幅为1.15%。其相关个股中，晶泰控股-P、华康生物医学、帝王国际投资涨幅较大，振幅较大的相关个股有晶泰控股-P、帝王国际投资、创胜集团-B，振幅分别为18.53%、18.37%、18.03%。该公司的部门包括北美和欧洲以及中国。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216141554984c63d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216141554984c63d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","01521","BK1576","BK1583"],"gpt_icon":0},{"id":"2491967833","title":"方达控股(01521)上涨5.37%，报1.57元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2491967833","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491967833?lang=zh_cn&edition=full","pubTime":"2024-12-13 10:20","pubTimestamp":1734056406,"startTime":"0","endTime":"0","summary":"12月13日，方达控股(01521)盘中上涨5.37%，截至10:20，报1.57元/股，成交127.39万元。方达控股公司是一家提供全方位一体化的医药研发合同研究服务，主要为仿制药和创新药公司提供从新药可行性研究到临床研究的全过程产品开发服务。公司已成功帮助客户将数以百计的化合物从产品研发阶段推进到商业化，遵循严谨的科学技术和质量体系，确保每个项目的高品质及合规性。截至2024年中报，方达控股营业总收入9.16亿元、净利润-83.38万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/13102046347045.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01521","BK1141","BK1583","BK1576"],"gpt_icon":0},{"id":"2491399505","title":"方达控股盘中异动 早盘急速上涨5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491399505","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491399505?lang=zh_cn&edition=full","pubTime":"2024-12-13 10:19","pubTimestamp":1734056370,"startTime":"0","endTime":"0","summary":"2024年12月13日早盘10时19分，方达控股股票出现异动，股价快速上涨5.37%。截至发稿，该股报1.570港元/股，成交量65万股，换手率0.03%，振幅5.37%。资金方面，该股资金流入86.004万港元，流出12.558万港元。机构评级方面，在所有2家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。方达控股股票所在的生物技术行业中，整体跌幅为0.36%。该公司的部门包括北美和欧洲以及中国。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213101930a1eaa5ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213101930a1eaa5ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1583","01521","BK1576"],"gpt_icon":0},{"id":"2490030234","title":"方达控股盘中异动 早盘股价大涨5.04%报1.460港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490030234","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490030234?lang=zh_cn&edition=full","pubTime":"2024-12-10 11:01","pubTimestamp":1733799710,"startTime":"0","endTime":"0","summary":"2024年12月10日早盘11时01分，方达控股股票出现异动，股价急速拉升5.04%。截至发稿，该股报1.460港元/股，成交量144万股，换手率0.07%，振幅6.47%。资金方面，该股资金流入179.26万港元，流出9.788万港元。方达控股股票所在的生物技术行业中，整体跌幅为0.80%。其相关个股中，思路迪医药股份、方达控股、科济药业-B涨幅较大，振幅较大的相关个股有华康生物医学、来凯医药-B、晶泰控股-P，振幅分别为12.50%、11.94%、11.30%。中国部门包括中国。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210110150984ae7f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241210110150984ae7f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1583","01521","BK1576"],"gpt_icon":0},{"id":"2490767148","title":"方达控股盘中异动 急速上涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490767148","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490767148?lang=zh_cn&edition=full","pubTime":"2024-12-09 09:38","pubTimestamp":1733708305,"startTime":"0","endTime":"0","summary":"2024年12月09日早盘09时38分，方达控股股票出现异动，股价急速上涨5.22%。截至发稿，该股报1.410港元/股，成交量10.4万股，换手率0.01%，振幅2.99%。方达控股股票所在的生物技术行业中，整体涨幅为1.62%。其相关个股中，圣诺医药-B、云康集团、药明康德涨幅较大，振幅较大的相关个股有药明生物、晶泰科技、药明康德，振幅分别为8.42%、7.03%、6.50%。中国部门包括中国。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120909382598e6647e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120909382598e6647e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","BK1576","BK1583","01521"],"gpt_icon":0},{"id":"2489702704","title":"方达控股(01521)上涨5.34%，报1.38元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2489702704","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489702704?lang=zh_cn&edition=full","pubTime":"2024-12-06 15:59","pubTimestamp":1733471988,"startTime":"0","endTime":"0","summary":"12月6日，方达控股(01521)盘中上涨5.34%，截至15:59，报1.38元/股，成交245.19万元。方达控股公司是一家提供全方位一体化的医药研发合同研究服务，主要为仿制药和创新药公司提供从新药可行性研究到临床研究的全过程产品开发服务。公司已成功帮助客户将数以百计的化合物从产品研发阶段推进到商业化，遵循严谨的科学技术和质量体系，确保每个项目的高品质及合规性。截至2024年中报，方达控股营业总收入9.16亿元、净利润-83.38万元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/06155946095191.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1141","BK1583","01521","BK1576"],"gpt_icon":0},{"id":"2489401104","title":"方达控股盘中异动 快速拉升5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489401104","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489401104?lang=zh_cn&edition=full","pubTime":"2024-12-06 15:59","pubTimestamp":1733471985,"startTime":"0","endTime":"0","summary":"2024年12月06日临近收盘15时59分，方达控股股票出现波动，股价快速上涨5.34%。截至发稿，该股报1.380港元/股，成交量183万股，换手率0.09%，振幅6.87%。资金方面，该股资金流入132.766万港元，流出105.796万港元。机构评级方面，在所有2家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。方达控股股票所在的生物技术行业中，整体涨幅为1.64%。北美和欧洲部门包括美国、加拿大和欧洲。中国部门包括中国。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120615594598e5ceaf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120615594598e5ceaf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01521","BK1141","BK1583","BK1576"],"gpt_icon":0},{"id":"2488844481","title":"方达控股(01521)上涨5.6%，报1.32元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2488844481","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488844481?lang=zh_cn&edition=full","pubTime":"2024-12-04 11:19","pubTimestamp":1733282358,"startTime":"0","endTime":"0","summary":"12月4日，方达控股(01521)盘中上涨5.6%，截至11:19，报1.32元/股，成交162.39万元。方达控股公司是一家提供全方位一体化的医药研发合同研究服务，主要为仿制药和创新药公司提供从新药可行性研究到临床研究的全过程产品开发服务。公司已成功帮助客户将数以百计的化合物从产品研发阶段推进到商业化，遵循严谨的科学技术和质量体系，确保每个项目的高品质及合规性。截至2024年中报，方达控股营业总收入9.16亿元、净利润-83.38万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/04111945990288.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1141","BK1583","01521","BK1576"],"gpt_icon":0},{"id":"2488118436","title":"方达控股盘中异动 早盘急速上涨5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488118436","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488118436?lang=zh_cn&edition=full","pubTime":"2024-12-04 11:19","pubTimestamp":1733282355,"startTime":"0","endTime":"0","summary":"2024年12月04日早盘11时19分，方达控股股票出现异动，股价急速上涨5.60%。截至发稿，该股报1.320港元/股，成交量125.4万股，换手率0.06%，振幅4.80%。资金方面，该股资金流入82.598万港元，流出66.012万港元。方达控股股票所在的生物技术行业中，整体跌幅为0.81%。其相关个股中，晶泰科技、方达控股、华康生物医学涨幅较大，振幅较大的相关个股有晶泰科技、来凯医药-B、宜明昂科-B，振幅分别为15.89%、10.29%、8.28%。中国部门包括中国。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204111915abf468e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204111915abf468e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1141","BK1576","01521"],"gpt_icon":0},{"id":"2486844890","title":"方达控股(01521)上涨5.5%，报1.15元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2486844890","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486844890?lang=zh_cn&edition=full","pubTime":"2024-11-27 14:30","pubTimestamp":1732689007,"startTime":"0","endTime":"0","summary":"11月27日，方达控股(01521)盘中上涨5.5%，截至14:30，报1.15元/股，成交122.8万元。方达控股公司是一家提供全方位一体化的医药研发合同研究服务，主要为仿制药和创新药公司提供从新药可行性研究到临床研究的全过程产品开发服务。公司已成功帮助客户将数以百计的化合物从产品研发阶段推进到商业化，遵循严谨的科学技术和质量体系，确保每个项目的高品质及合规性。截至2024年中报，方达控股营业总收入9.16亿元、净利润-83.38万元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/27143045739012.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01521","BK1583","BK1576","BK1141"],"gpt_icon":0},{"id":"2486897114","title":"方达控股盘中异动 大幅上涨5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486897114","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486897114?lang=zh_cn&edition=full","pubTime":"2024-11-27 14:17","pubTimestamp":1732688267,"startTime":"0","endTime":"0","summary":"2024年11月27日下午盘14时17分，方达控股股票出现异动，股价急速拉升5.50%。截至发稿，该股报1.150港元/股，成交量51.6万股，换手率0.03%，振幅7.34%。资金方面，该股资金流入45.264万港元，流出12.396万港元。机构评级方面，在所有2家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。方达控股股票所在的生物技术行业中，整体涨幅为1.73%。北美和欧洲部门包括美国、加拿大和欧洲。中国部门包括中国。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127141748a258f8c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127141748a258f8c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01521","BK1576","BK1141","BK1583"],"gpt_icon":0},{"id":"2486862184","title":"港股异动 | CRO概念股早盘回暖 海外投融资逐渐恢复 医药细分领域及新兴业务有望快速发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2486862184","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486862184?lang=zh_cn&edition=full","pubTime":"2024-11-27 11:02","pubTimestamp":1732676570,"startTime":"0","endTime":"0","summary":"西南证券发布研报称，2024年前三季度，CXO行业收入逐季回升，但利润整体仍有承压。受益于国内CXO产业链的全面以及竞争力的领先，行业受地缘政治影响目前较为有限。国内临床前及临床CRO价格趋稳，经营趋势有望逐渐向上。近年来在ADC、多肽药物快速发展下，相关CXO需求迅速增加，小核酸、CGT等细分领域也有望迎来快速发展。长期来看，我们仍旧看好CXO板块发展潜力及成长空间。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1216426.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01521","BK1576","LU0823426308.USD","LU1688375341.USD","LU0348825331.USD","LU0417516738.SGD","BK1521","LU0456846285.SGD","HK0000306701.USD","LU0823426480.USD","LU0359201612.USD","02269","LU0052750758.USD","03347","LU0516423174.USD","LU0417516902.SGD","HK0000306685.HKD","IE00B0JY6N72.USD","BK1515","LU0326950275.SGD","LU0588546209.SGD","BK1610","LU0979878070.USD","LU1242518931.SGD","LU1794554557.SGD","LU0307460666.USD","LU0819121731.USD","LU0856984785.SGD","LU0516422366.SGD","LU0708995583.HKD","BK1589","LU0043850808.USD","159938","LU0456827905.SGD","09939","06127","LU0516423091.SGD","SG9999002562.SGD","LU0039217434.USD","LU0327786744.USD","LU0181495838.USD","01548","BK1583","BK1141","LU0359202008.SGD","SG9999002463.SGD","LU0320764599.SGD","HK0000320264.USD","BK1161","BK1574"],"gpt_icon":0},{"id":"2486740746","title":"方达控股(01521)上涨5.66%，报1.12元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2486740746","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486740746?lang=zh_cn&edition=full","pubTime":"2024-11-25 10:53","pubTimestamp":1732503191,"startTime":"0","endTime":"0","summary":"11月25日，方达控股(01521)盘中上涨5.66%，截至10:53，报1.12元/股，成交100.82万元。方达控股公司是一家提供全方位一体化的医药研发合同研究服务，主要为仿制药和创新药公司提供从新药可行性研究到临床研究的全过程产品开发服务。公司已成功帮助客户将数以百计的化合物从产品研发阶段推进到商业化，遵循严谨的科学技术和质量体系，确保每个项目的高品质及合规性。截至2024年中报，方达控股营业总收入9.16亿元、净利润-83.38万元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/25105345628970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1583","01521","BK1576","BK1141"],"gpt_icon":0},{"id":"2486102747","title":"方达控股盘中异动 急速上涨5.66%报1.120港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486102747","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486102747?lang=zh_cn&edition=full","pubTime":"2024-11-25 10:14","pubTimestamp":1732500888,"startTime":"0","endTime":"0","summary":"2024年11月25日早盘10时14分，方达控股股票出现波动，股价大幅上涨5.66%。截至发稿，该股报1.120港元/股，成交量22.4万股，换手率0.01%，振幅2.83%。资金方面，该股资金流入24.748万港元，流出0港元。机构评级方面，在所有2家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。方达控股股票所在的生物技术行业中，整体涨幅为0.61%。该公司的部门包括北美和欧洲以及中国。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125101448a2532620&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125101448a2532620&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1576","01521","BK1141"],"gpt_icon":0},{"id":"2484139618","title":"方达控股盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484139618","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484139618?lang=zh_cn&edition=full","pubTime":"2024-11-20 11:09","pubTimestamp":1732072154,"startTime":"0","endTime":"0","summary":"2024年11月20日早盘11时09分，方达控股股票出现异动，股价大幅拉升5.00%。截至发稿，该股报1.050港元/股，成交量50.8万股，换手率0.02%，振幅4.00%。资金方面，该股资金流入35.818万港元，流出8.308万港元。机构评级方面，在所有2家参与评级的机构中，100%的券商给予持有建议，无券商给予买入、卖出建议。方达控股股票所在的生物技术行业中，整体涨幅为2.04%。北美和欧洲部门包括美国、加拿大和欧洲。中国部门包括中国。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112011091498e43a6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112011091498e43a6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01521","BK1141","BK1583","BK1576"],"gpt_icon":0},{"id":"2484139735","title":"方达控股(01521)股价上升5%，现价港币$1.05","url":"https://stock-news.laohu8.com/highlight/detail?id=2484139735","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484139735?lang=zh_cn&edition=full","pubTime":"2024-11-20 11:09","pubTimestamp":1732072140,"startTime":"0","endTime":"0","summary":"[上升股]方达控股(01521) 股价在上午11:09比前收市价上升5%，现股价为港币$1.05。至目前为止，今日最高价为$1.05，而最低价为$1.01。总成交量为50万股，总成交金额为港币$51.32万。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190515141041255_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR241120551/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1141","01521","BK1583","BK1576"],"gpt_icon":0},{"id":"2484513577","title":"医药外包概念普升 昭衍新药(06127)涨5.11% 机构称CXO板块有望受益于海外研发需求复苏","url":"https://stock-news.laohu8.com/highlight/detail?id=2484513577","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484513577?lang=zh_cn&edition=full","pubTime":"2024-11-20 10:53","pubTimestamp":1732071235,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药外包概念普升，昭衍新药 涨5.11%，泰格医药涨4.33%，方达控股涨2%，康龙化成涨1.84%，药明生物跟涨0.79%。招银国际发研指，MSCI中国医疗指数年初至今累计下跌17.9%，跑输MSCI中国指数32.4%。受益于海外降息以及国内宏观环境改善，医药作为高弹性行业有望跑赢市场。随着政策焦点转向刺激经济，该行认为医疗设备更新政策有望加速落地，推动国产医疗设备企业盈利复苏。CXO板块有望受益于海外研发需求复苏，《生物安全法案》的影响或将有限。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241105/OGZjY2Y5NjEzNTIxNjU5NDU5.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241105/OGZjY2Y5NjEzNTIxNjU5NDU5.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1948062","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516422440.USD","LU0348735423.USD","LU0359201612.USD","LU0572944931.SGD","LU0823426480.USD","LU0979878070.USD","03347","SG9999002463.SGD","159938","BK1521","LU0456827905.SGD","BK1515","03759","LU1242518931.SGD","BK1576","BK1610","LU0320764599.SGD","BK0216","CXO","LU1880383366.USD","06127","02269","SG9999002562.SGD","LU1688375341.USD","LU0823426308.USD","LU0588546209.SGD","LU0052750758.USD","BK1589","LU0456846285.SGD","LU0417516738.SGD","LU0307460666.USD","IE00B0JY6N72.USD","LU0051755006.USD","LU0417516902.SGD","LU0359202008.SGD","09939","LU1720050803.USD","LU2039709279.SGD","BK1161","LU0819121731.USD","BK1141","603127","LU0516422952.EUR","LU0181495838.USD","01521","LU0516423091.SGD","LU0348825331.USD","LU0327786744.USD","LU0140636845.USD","LU0043850808.USD"],"gpt_icon":0},{"id":"2483214842","title":"方达控股11月14日主力资金流出23万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2483214842","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483214842?lang=zh_cn&edition=full","pubTime":"2024-11-14 16:16","pubTimestamp":1731572187,"startTime":"0","endTime":"0","summary":"11月14日, 方达控股股价涨0.96%，报收1.05元，成交金额502万元，换手率0.23%，振幅9.62%，量比1.67。方达控股今日主力资金净流出23万元，连续3日净流出，上一交易日主力净流出28万元，今日环比减少17.86%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为66.67%，平均跌幅为4.19%。该股近5个交易日上涨15.22%，主力资金累计净流出26万元；近20日主力资金累计净流入105万元，其中净流入天数为6日。该股主力净额占比0.01%，港股市场排名2347/2644。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114161718a236c4a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114161718a236c4a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1576","01521","BK1141"],"gpt_icon":0},{"id":"2483895337","title":"方达控股(01521)上涨5.77%，报1.1元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483895337","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483895337?lang=zh_cn&edition=full","pubTime":"2024-11-14 10:26","pubTimestamp":1731551211,"startTime":"0","endTime":"0","summary":"11月14日，方达控股(01521)盘中上涨5.77%，截至10:26，报1.1元/股，成交117.46万元。方达控股公司是一家提供全方位一体化的医药研发合同研究服务，主要为仿制药和创新药公司提供从新药可行性研究到临床研究的全过程产品开发服务。公司已成功帮助客户将数以百计的化合物从产品研发阶段推进到商业化，遵循严谨的科学技术和质量体系，确保每个项目的高品质及合规性。截至2024年中报，方达控股营业总收入9.16亿元、净利润-83.38万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/14102645277818.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01521","BK1576","BK1141","BK1583"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.frontagelab.com","stockEarnings":[{"period":"1week","weight":0.1259},{"period":"1month","weight":0.5941},{"period":"3month","weight":1.6393},{"period":"6month","weight":0.7692},{"period":"1year","weight":-0.2546},{"period":"ytd","weight":-0.306}],"compareEarnings":[{"period":"1week","weight":-0.0144},{"period":"1month","weight":0.0147},{"period":"3month","weight":0.1028},{"period":"6month","weight":0.1018},{"period":"1year","weight":0.2035},{"period":"ytd","weight":0.1653}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"方达控股公司是一家为医药公司提供贯穿整个药物发现和开发过程的一体化，科学驱动的研究、分析和开发服务的合同研究机构。其提供的服务包括药物代谢和药代动力学、安全性和毒理学及化学、制造和控制，农业化学服务以及临床研究支持的相关服务，其中包括早期临床服务和生物识别服务。该公司主要通过其美国全资附属公司Frontage Laboratories, Inc.和中国全资附属公司方达医药技术（上海）有限公司提供服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.042481},{"month":2,"riseRate":0.4,"avgChangeRate":0.012923},{"month":3,"riseRate":0,"avgChangeRate":-0.166045},{"month":4,"riseRate":0.6,"avgChangeRate":-0.007906},{"month":5,"riseRate":0.6,"avgChangeRate":0.060919},{"month":6,"riseRate":0.5,"avgChangeRate":0.036341},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.068729},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.056866},{"month":9,"riseRate":0.333333,"avgChangeRate":0.043467},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.036824},{"month":11,"riseRate":0.666667,"avgChangeRate":0.124976},{"month":12,"riseRate":0.833333,"avgChangeRate":0.131677}],"exchange":"SEHK","name":"方达控股","nameEN":"FRONTAGE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"方达控股(01521)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供方达控股(01521)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"方达控股,01521,方达控股股票,方达控股股票老虎,方达控股股票老虎国际,方达控股行情,方达控股股票行情,方达控股股价,方达控股股市,方达控股股票价格,方达控股股票交易,方达控股股票购买,方达控股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"方达控股(01521)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供方达控股(01521)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}